Drw Securities, LLC Genocea Biosciences, Inc. Transaction History

Drw Securities, LLC

  • $2.47 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$1.26 - $2.73 $74,673 - $161,793
-59,265 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$2.9 - $4.07 $84,868 - $119,108
29,265 Added 97.55%
59,265 $172,000
Q2 2019

Aug 14, 2019
BUY
$3.47 - $6.71 $104,100 - $201,300
30,000 New
30,000 $118,000

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0
View Full List

About GENOCEA BIOSCIENCES, INC.

GNCA Quotes by TradingView
  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email